| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Cell &Genetic Therapies
2 companies
Sanna Bastiano is an EVP, Cell &Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 2 sells.
Estimated insider holdings value: $14.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Cell &Genetic Therapies | Sell | 1,686 | $210.56 | $355,012.33 | -2.1% | +1.0% | +11.1% |